SCHEMBL758540

SCHEMBL758540

Cc1ccc(-c2ccc(N3C(=O)c4ccc5c6c(ccc(c46)C3=O)C(=O)N(C)C5=O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
RAB9A P51151 2/20 0.53
HSD17B10 Q99714 2/20 0.53
NPC1 O15118 1/20 0.53
TSHR P16473 1/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
POLB P06746 3/20 0.51
APAF1 O14727 1/20 0.51
KDM4E B2RXH2 2/20 0.49
CA9 Q16790 4/20 0.49
CA12 O43570 3/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 2/20 0.47
ADORA2A P29274 1/20 0.46
HPGD P15428 2/20 0.46
F2 P00734 1/20 0.46
ELANE P08246 1/20 0.46
CTSG P08311 1/20 0.46
CMA1 P23946 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13533868 0.95 ALDH1A1 (0.62) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL13533870 0.89 ALDH1A1 (0.59) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL13018342 0.89 ALDH1A1 (0.59) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL11990862 0.88 ALDH1A1 (0.70) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL7591247 0.87 ALDH1A1 (0.61) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL760721 0.86 ALDH1A1 (0.53) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL13886580 0.86 ALDH1A1 (0.53) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL757749 0.84 CA9 (0.56) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL13294565 0.82 ALDH1A1 (0.52) ALDH1A1RAB9AHSD17B10NPC1TSHR
SCHEMBL757748 0.82 MEN1 (0.61) ALDH1A1RAB9AHSD17B10NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8376149-B2 Crosslinked polymer film bearing ionic groupings SOLVAY SA (BE) 2013-02-19 US disclosed
US-8211558-B2 Crosslinked polymer electrolyte and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-03 US disclosed
US-8138231-B2 Polymer having oxycarbon group, and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-20 US disclosed
US-20090274943-A1 CROSSLINKED POLYMER ELECTROLYTE AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-11-05 US disclosed
US-20090233142-A2 POLYMER HAVING OXOCARBON GROUP, AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-09-17 US disclosed
US-20090110995-A1 POLYMER HAVING OXYCARBON GROUP, AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-30 US disclosed
US-20080290022-A1 Crosslinked Polymer Film Bearing Ionic Groupings SOLVAY SA (BE) 2008-11-27 US disclosed
US-20070218335-A1 POLYMER HAVING OXOCARBON GROUP, AND USE THEREOF KAO CORPORATION (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080290022-A1 Crosslinked Polymer Film Bearing Ionic Groupings PARG, GLG1, GNG2 ALDH1A1 2369/4885RAB9A 582/4885HSD17B10 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.